Rhenovia Pharma RSS En http://www.rhenovia.com/pages/home.php?lang=En <![CDATA[Rhenovia Pharma opens now its 2nd Round of Financing to individuals, companies and investment organizations]]> 2013-05-12T12:00:00 AM GMT http://www.rhenovia.com/pages/article.php?article=441&lang=En <![CDATA[Article in the economic newspaper La Tribune: 2nd Round of Fund Raising targetting 2.5 million euros to accelerate research on brain diseases of the nervous system ]]> 2013-04-29T12:00:00 AM GMT http://www.rhenovia.com/pages/article.php?article=440&lang=En <![CDATA[RHEDAR™: a former Phase II drug repositioned by help of biosimulation in neurodegenerative diseases presented at the Huntington’s disease congress]]> 2013-04-04T12:00:00 AM GMT http://www.rhenovia.com/pages/article.php?article=438&lang=En <![CDATA[Press Announcement: Rhenovia recognized as the world leader in biosimulation of the central nervous system]]> 2013-02-04T12:00:00 AM GMT http://www.rhenovia.com/pages/article.php?article=435&lang=En <![CDATA[Press announcement: Rhenovia Pharma recognized as the world leader in biosimulation of the central nervous system ]]> 2013-02-04T12:00:00 AM GMT http://www.rhenovia.com/pages/article.php?article=436&lang=En